Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization

Journal of the American Academy of Nurse Practitioners

Volumn 18, Issue 9, 2006, Pages 436-444

  Paez, Kathryn A ^a   Allen, Jerilyn K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Coronary heart disease; Cost effectiveness; Hypercholesterolemia; Nurse case management

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AFTERCARE; AGED; ARTICLE; BLOOD; CARDIOLOGY; CASE MANAGEMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; DRUG MONITORING; ECONOMICS; FEMALE; HEALTH CARE QUALITY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; LIVER FUNCTION TEST; MALE; MIDDLE AGED; NURSE ATTITUDE; NURSE PRACTITIONER; NURSING; NURSING EVALUATION RESEARCH; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; SALARY AND FRINGE BENEFIT;

AFTERCARE; AGED; ANTICHOLESTEREMIC AGENTS; CARDIOLOGY; CASE MANAGEMENT; CHOLESTEROL, LDL; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG MONITORING; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; NURSE PRACTITIONERS; NURSE'S ROLE; NURSING EVALUATION RESEARCH; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION; PROGRAM EVALUATION; SALARIES AND FRINGE BENEFITS;

EID: 33750620655     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2006.00159.x     Document Type: Article

References (38)

1. Allen J. K. Blumenthal R. S. Margolis S. Young D. R. Miller E. R. III. Kelly K 2002 Nurse case management of hypercholesterolemia in patients with coronary heart disease: Results of a randomized clinical trial American Heart Journal 144 678 686
2. Avorn J. Monette J. Lacour A. Bohn R. L. Monane M. Mogun H et al 1998 Persistence of use of lipid-lowering medications: A cross-national study The Journal of the American Medical Association 279 1458 1462
3. Bachorik P. S. Cloey T. A. Finney C. A. Lowry D. R. Becker D. M 1991 Lipoprotein-cholesterol analysis during screening: Accuracy and reliability Annuals of Internal Medicine 114 741 747
4. Bachorik P. S. Ross J. W 1995 National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement Clinical Chemistry 41 1414 1420
5. Becker D. M. Raqueno J. V. Yook R. M. Kral B. G. Blumenthal R. S. Moy T. F et al 1998 Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease Archives of Internal Medicine 158 1533 1539
6. Benner J. S. Glynn R. J. Mogun H. Neumann P. J. Weinstein M. C. Avorn J 2002 Long-term persistence in use of statin therapy in elderly patients The Journal of the American Medical Association 288 455 461
7. Centers for Medicare and Medicaid Services 2005 Health care indicators Retrieved February 2005 from the CMS Web site
8. DeBusk R. F. Miller N. H. Superko H. R. Dennis C. A. Thomas R. J. Lew H. T et al 1994 A case-management system for coronary risk factor modification after acute myocardial infarction Annals of Internal Medicine 120 721 729
9. Drummond M. F. O'Brien B. Stoddart G. L. Torrance G. W 2004 Methods for the economic evaluation of health care programmes 2nd ed New York Oxford Medical Publications
10. Friedewald W. T. Levy R. I. Fredrickson D. S 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 18 499 502
11. Frolkis J. P. Zyzanski S. J. Schwartz J. M. Suhan P. S 1998 Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines Circulation 98 851 855
12. Ganz D. A. Kuntz K. M. Jacobson G. A. Avorn J 2000 Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction Annals of Internal Medicine 132 780 787
13. Harnick D. J. Cohen J. L. Schechter C. B. Fuster V. Smith D. A 1998 Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease American Journal of Cardiology 81 1416 1420
14. Heart Protection Study Collaborative Group 2002 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebo-controlled trial Lancet 360 7 22
15. Hoerger T. J. Bala M. V. Bray J. W. Wilcosky T. C. LaRosa J 1998 Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults American Journal of Cardiology 82 61 65
16. Hoogwerf B. J. Frolkis J. P. Pearce G. P Vidt D. Pashkow F. J. Cross J. A et al 1999 Use of treatment algorithms by physician extenders in a preventive cardiology clinic for LDL cholesterol, blood pressure and HgA1c in diabetic patients. Abstract presented at the American Heart Association 72nd Scientific Sessions, Atlanta, Georgia, November 8, 1999
17. Jackevicius C. A. Mamdani M. Tu J. V 2002 Adherence with statin therapy in elderly patients with and without acute coronary syndromes The Journal of the American Medical Association 288 462 467
18. Johannesson M. Jonsson B. Kjekshus J. Olsson A. G. Pedersen T. R. Wedel H et al 1997 Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease The New England Journal of Medicine 336 332 336
19. Knatterud G. L. Rosenberg Y. Campeau L. Geller N. L. Hunninghake D. B. Forman S. A et al 2000 Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators Circulation 102 157 165
20. Miller M. Byington R. Hunninghake D. Pitt B. Furberg C. D for the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial Investigators 2000 Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada Archives of Internal Medicine 160 343 347
21. Pearson T. A. Laurora I. Chu H. Kafonek S 2000 The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Archives of Internal Medicine 160 459 467
22. Pedersen T. R. Kjekshus J. Berg K. Haghfelt T. Faergeman O. Thorgeirsson G et al 2004 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4S) Atherosclerosis Supplement 5 81 87
23. Pitt B. Waters D. Brown W. V. van Boven A. J. Schwartz L. Title L. M et al 1999 Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease The New England Journal of Medicine 341 70 76
24. Plehn J. F. Davis B. R. Sacks F. M. Rouleau J. L. Pfeffer M. A. Bernstein V et al 1999 Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study Circulation 99 216 223
25. Prosser L. A. Stinnett A. A. Goldman P. A. Williams L. W. Hunink M. G. M. Goldman L et al 2000 Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics Annals of Internal Medicine 132 769 779
26. Sacks F. M. Pfeffer M. A. Moye L. A. Rouleau J. L. Rutherford J. D. Cole T. G et al 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels The New England Journal of Medicine 335 1001 1009
27. Schwartz G. G. Olsson A. G. Ezekowitz M. D. Ganz P. Oliver M. F. Waters D et al 2001 Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial The Journal of the American Medical Association 285 1711 1718
28. Shepherd J. Blauw G. Murphy M. Bollen E. Buckley B. Cobbe S et al 2002 Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized placebo-controlled trial Lancet 360 1623 1630
29. Shepherd J. Cobbe S. M. Ford I. Isles C. G. Lorimer A. R. Macfarlane P. W et al 1995 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia The New England Journal of Medicine 333 1301 1308
30. Simons L. A. Levis G. Simons J 1996 Apparent discontinuation rates in patients prescribed lipid lowering drugs Medical Journal of Australia 164 208 211
31. Stuart-Shor E. Skinner S. McCleary N. C et al 1999 A nurse-directed community-based, integrated multiple cardiac risk-redcution program: Physiologic and behavioral outcomes [Abstract] Circulation, 100
32. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group 1998 Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels The New England Journal of Medicine 339 1349 1357
33. The Post Coronary Artery Bypass Graft Trial Investigators 1997 The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts The New England Journal of Medicine 336 153 163
34. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel 2001a Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Pressure Cholesterol in Adults (Adult Treatment Panel III) Executive Summary Rep. No. 01-3670 Washington, DC National Heart, Lung, and Blood Institute, National Institutes of Health
35. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel 2001b Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 3143 3421
36. U.S. Department of Health and Human Services & Health Resources and Service Administration 2000 Findings from the National Sample Survey of Registered Nurses Retrieved February 2005 from the USDHHS Web site
37. Weinstein M. C. Siegel J. E. Gold M. R. Kamlet M. S. Russell L. B 1996 Recommendations of the panel on cost-effectiveness in health and medicine The Journal of the American Medical Association 276 1253 1258
38. West J. A. Miller N. H. Parker K. M Senneca D. Ghandour G. Clark M et al 1997 A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization American Journal of Cardiology 79 58 63